Ocular Therapeutix, Inc. announced the appointment of Kevin Hanley as Senior Vice President, Technical Operations and Naymisha Patel as Vice President of Quality. Kevin Hanley brings over 30 years of experience managing biotechnology and pharmaceutical operations with demonstrated success in technology transfer and process scale-up for the manufacturing of proteins from development through commercialization. Most recently, Patel served as the Head of Global Quality at Prothena Corporation plc, before which she served as Vice President, Regulatory and Quality of StemCells, Inc.